Original Research

Outcomes in Critical COVID 19 Infection Affected by Pre-Existing Diabetes Mellitus

Bilal Saeed
Department of Nephrology, Pak Emirates Military Hospital Rawalpindi
Abdul Rehman Arshad
Department of Nephrology, Pak Emirates Military Hospital Rawalpindi
Hafiz Muhammad Yasir Rehman
Department of Nephrology, Pak Emirates Military Hospital Rawalpindi

✉ Correspondence: Bilal Saeed Email: ayubian2019@gmail.com

DOI https://doi.org/10.70302/jpsim.v4i1.2305
Volume: 4, Issue 1 Pages: 20–23 Published: 13 Feb 2023
Received: 13 Nov 2022 Accepted: 29 Nov 2022 Published Online: 13 Feb 2023

Abstract

Objective

To determine the effect of pre-existing diabetes mellitus on disease course in COVID-19 infection.

Methodology

This retrospective observational study was done from Jan 2021 to August 2021. We included patients with COVID-19 infection having a positive PCR for SARS-CoV-2. Exclusion criteria included missing data or a negative PCR for SARS-CoV-2. Patients were selected using consecutive sampling. Length of stay and death within hospital were compared amongst diabetic and non- diabetic patients.

Results

The 279 patients were aged 52.53± 11.31 years. Of these, 216 (77.42%) were males and 92 (32.97%) had diabetes. They remained admitted for 10.18± 3.13 days. The period of hospitalization was similar in diabetics and non- diabetics (10.70± 3.51 days vs 9.92± 2.91 days; p=0.052). Amongst the diabetics, 43(46.74%) died in hospital in comparison with 53 (39.55%) non- diabetics (p=0.002). The risk of in-hospital death in diabetics was 1.673 (95% CI 1.207 - 2.319).

Conclusion

Diabetes mellitus is linked with greater risk of death, longer duration of hospital stay and higher need for critical care and novel therapy in COVID-19 infection.

Keywords
hospital stay mortality pandemic pneumonia

How to Cite This Article

Saeed B, Arshad AR, Rehman HMY. Outcomes in Critical COVID 19 Infection Affected by Pre-Existing Diabetes Mellitus. J Pak Soc Intern Med. 2023;4(1):20–23. doi:10.70302/jpsim.v4i1.2305

⭳ Download XML (JATS) ⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

Data Availability

Data are available from the corresponding author on reasonable request.

References

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-33.
  2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-69.
  3. Li G, Chen Z, Lv Z, Li H, Chang D, Lu J. Diabetes mellitus and COVID-19: associations and possible mechanisms. Int J Endocrinol. 2021; PMC 7394378.
  4. Corrao S, Pinelli K, Vacca M, Raspanti M, Argano C. Type 2 diabetes mellitus and COVID-19: a narrative review. Front Endocrinol. 2021; doi: 10.3389/fendo.2021.609470. doi:10.3389/fendo.2021.609470
  5. Hui Y, Li Y, Tong X, Wang Z, Mao X, Huang L, et al. The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan. PLoS One. 2020; 15(12):e0243602.
  6. National Institutes of Health. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Maryland: Available from: [https://www.covid19treatmentguidelines.nih.gov/]
  7. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94(1):91-95.
  8. Chen Y, Gong X, Wang L, Guo J. Effects of Hypertension, Diabetes and Coronary Heart Disease on COVID-19 Diseases Severity: A Systematic Review and Meta-Analysis. medRxiv 2020;doi: https://doi.org/10.1101/2020.03.25.20043133. doi:10.1101/2020.03.25.20043133
  9. Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020; 31(6):1068-1077.e3.
  10. Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol. 2020;14(4):813-821.
  11. Azar WS, Njeim R, Fares AH, Azar NS, Azar ST, El Sayed M, et al. COVID-19 and diabetes mellitus: how one pandemic worsens the other. Rev Endocr Metab Disord. 2020;21(4):451-463.
  12. Zhang W, Li C, Xu Y, He B, Hu M, Cao G, et al. Hyperglycemia and correlated high levels of inflammation have a positive relationship with the severity of coronavirus disease 2019. Mediators Inflamm. 2021; Article ID 8812304.
  13. Shauly-Aharonov M, Shafrir A, Paltiel O, Calderon-Margalit R, Safadi R, Bicher R, et al. Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study. PLoS One. 2021; 16(7):e0254847.
  14. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol. 2020; doi: 10.1016/j.jcv.2020.104354. doi:10.1016/j.jcv.2020.104354
  15. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584(7821):430-6.
  16. Saeed B, Arshad AR. Outcome of severe/critical Covid-19 infection in patients with
  17. and without diabetes mellitus. Khyber Med Univ J. 2021;13(Suppl 1):S9.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. Authors retain copyright. © 2023 The Author(s).